ArticleOncotarget2016

Gankyrin sustains PI3K/GSK-3β/β-catenin signal activation and promotes colorectal cancer aggressiveness and progression.

Feng He et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.